Free Trial

Embree Financial Group Raises Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Embree Financial Group increased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 64.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 83,212 shares of the company's stock after purchasing an additional 32,500 shares during the quarter. Ryan Specialty makes up approximately 0.9% of Embree Financial Group's portfolio, making the stock its 23rd biggest holding. Embree Financial Group's holdings in Ryan Specialty were worth $5,339,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of RYAN. Xponance Inc. increased its stake in shares of Ryan Specialty by 67.2% in the second quarter. Xponance Inc. now owns 20,686 shares of the company's stock worth $1,198,000 after purchasing an additional 8,312 shares in the last quarter. Jennison Associates LLC grew its stake in Ryan Specialty by 60.2% in the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company's stock valued at $68,054,000 after buying an additional 385,366 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Ryan Specialty by 107.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock valued at $30,504,000 after acquiring an additional 238,064 shares during the period. Geneva Partners LLC purchased a new stake in shares of Ryan Specialty during the third quarter worth $2,537,000. Finally, Bar Harbor Wealth Management boosted its holdings in shares of Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock worth $10,835,000 after acquiring an additional 9,482 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Wall Street Analysts Forecast Growth

RYAN has been the subject of a number of recent analyst reports. Bank of America boosted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods reduced their target price on Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating for the company in a research report on Friday, January 10th. Wells Fargo & Company lowered their price target on Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 14th. The Goldman Sachs Group boosted their price objective on Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a report on Wednesday, October 9th. Finally, Morgan Stanley assumed coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $74.40.

View Our Latest Stock Report on RYAN

Ryan Specialty Trading Down 1.5 %

Shares of Ryan Specialty stock traded down $0.99 during trading on Friday, reaching $63.27. The company's stock had a trading volume of 1,379,301 shares, compared to its average volume of 757,048. The company has a market cap of $16.57 billion, a price-to-earnings ratio of 82.16, a PEG ratio of 1.14 and a beta of 0.72. The firm's 50-day moving average is $67.34 and its two-hundred day moving average is $66.21. Ryan Specialty Holdings, Inc. has a 52-week low of $42.21 and a 52-week high of $75.97. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same period in the prior year, the business posted $0.32 earnings per share. The company's revenue was up 20.5% on a year-over-year basis. On average, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty's dividend payout ratio (DPR) is presently 57.14%.

Insider Buying and Selling

In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the sale, the director now directly owns 45,409 shares in the company, valued at approximately $2,954,309.54. This trade represents a 39.35 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares of the company's stock, valued at approximately $884,236.54. This represents a 54.42 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,887 shares of company stock valued at $18,118,273 over the last three months. 11.10% of the stock is owned by company insiders.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Recommended Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines